Телефон
30 years of experience in bringing orphan drugs to the market for the treatment of orphan diseases, a portfolio of 18 products and a significant research and development program.
The company has unparalleled experience in developing clinical trials for orphan drugs and in meeting specific regulatory requirements.
The company's infrastructure has been designed to uniquely manufacture, package and distribute very small to large number of specialized products worldwide.
Recordati Rare Diseases is committed to improving the diagnosis and treatment of rare diseases.